Skip to main content

and
  1. Article

    Open Access

    Perioperative immunomodulation with interleukin-2 in patients with renal cell carcinoma: results of a controlled phase II trial

    We conducted a non-randomised controlled phase II trial to investigate the role of preoperative administration of interleukin-2 (IL-2) in patients with renal cell carcinoma undergoing tumour nephrectomy. A tot...

    T Klatte, A Ittenson, F-W Röhl, M Ecke, E P Allhoff, M Böhm in British Journal of Cancer (2006)